(Q37219391)

19 August 2017

title

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder (English)

1 reference

19 August 2017

C Allgulander

1

1 reference

19 August 2017

D Nutt

2

1 reference

19 August 2017

M Detke

3

1 reference

19 August 2017

J Erickson

4

1 reference

19 August 2017

M Spann

5

1 reference

19 August 2017

D Walker

6

1 reference

19 August 2017

S G Ball

7

1 reference

19 August 2017

J M Russell

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Journal of Psychopharmacology

19 August 2017

published in

1 reference

19 August 2017

volume

22

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

417-425

1 reference

Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF-REPORT RATINGS OF HOSPITALIZED DEPRESSIVES

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

Sociological influences on antidepressant prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091588

21 January 2018

Identifiers

DOI

10.1177/0269881108091588

1 reference

19 August 2017

1 reference